STOCK TITAN

Itron Inc Form 4 Filings

ITRI NASDAQ

Every Form 4 that Itron Inc (ITRI) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow ITRI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ITRI filings page.

Rhea-AI Summary

ITRON, INC. (ITRI) reported that Justin K. Patrick, its SVP, Device Solutions, sold a total of 10,210 shares of common stock on September 3, 2026 in multiple open-market transactions at a price of $97.36 per share. All reported sales were made under a Rule 10b5-1 trading plan adopted on May 6, 2026.

Rhea-AI Summary

ITRON, INC. (ITRI) insider Donald L. Reeves III, SVP, Outcomes, reported selling 283 shares of common stock on 2026-08-25 in an open-market transaction at $99.99 per share. The sale was made under a Rule 10b5-1 Trading Plan adopted on September 11, 2025, and he now holds 27,662 shares directly.

Rhea-AI Summary

ITRON, INC. (ITRI) reported an insider transaction by David Marshall Wright, VP, Corp. Controller & CAO. On August 24, 2026, he sold 76 shares of common stock at $98.79 per share. According to the company’s disclosure, these shares were automatically sold to cover tax withholding obligations from a restricted stock unit vesting, leaving him with 8,671 shares held directly.

Rhea-AI Summary

ITRON, INC. (ITRI) reported that officer Christopher E. Ware, SVP, GC & Corp. Secretary, had 200 shares of common stock sold on 2026-08-24 at $98.79 per share. According to the disclosure, these shares were automatically sold to cover tax withholding obligations from the vesting of a restricted stock unit award. After this transaction, Ware directly holds 29,916 shares of ITRON common stock.

Rhea-AI Summary

ITRON, INC. (ITRI) reported an insider transaction by Donald L. Reeves III, SVP, Outcomes. On 2026-08-24, 329 shares of common stock were sold at $98.79 per share, pursuant to an automatic sale to cover tax withholding obligations arising from the vesting of a restricted stock unit award. After this tax-related sale, Reeves directly held 27,945 shares of Itron common stock.

Rhea-AI Summary

ITRON, INC. (ITRI) reported an insider transaction by Laurie Ann Pulatie-Hahn, SVP, HR. On 2026-08-24, she sold 178 shares of common stock at $98.79 per share. A footnote states these shares were automatically sold to cover tax withholding obligations from the vesting of a restricted stock unit award. After this transaction, she directly holds 31,930 shares of ITRON common stock.

Rhea-AI Summary

Itron, Inc. (ITRI) reported that Patrick Justin K, its SVP, Device Solutions, reported a transaction in the company’s common stock. On 2026-08-24, 222 shares of common stock were sold at a price of $98.79 per share. According to the filing, these shares were automatically sold to cover tax withholding obligations arising from the vesting of a restricted stock unit award. Following this sale, the reporting person directly holds 32,275 shares of Itron common stock.

Rhea-AI Summary

ITRON, INC. (ITRI) reported that executive John F. Marcolini, SVP, Networked Solutions, had 331 shares of common stock sold on 2026-08-24 at $98.79 per share. According to the disclosure, these shares were automatically sold to cover tax withholding obligations from a restricted stock unit vesting, leaving him with 12,683 directly owned shares.

Rhea-AI Summary

ITRON, INC. (ITRI) reported that SVP & CFO Joan S. Hooper sold 455 shares of Common Stock on 2026-08-24 at $98.79 per share. According to the notes, these shares were automatically sold to cover tax withholding obligations from the vesting of a restricted stock unit award. After the sale, she directly held 118,440 shares.

Rhea-AI Summary

ITRON, INC. (ITRI) reported an insider transaction by President & CEO Thomas Deitrich. On 2026-08-24, he executed an open-market sale of 887 shares of common stock at $98.79 per share. The shares were automatically sold to cover tax withholding on vesting of a restricted stock unit award. After this transaction, he held 367,009 shares directly and 25,000 shares indirectly through a trust.

Rhea-AI Summary

ITRON, INC. (ITRI) reported that officer Donald L. Reeves III, SVP, Outcomes, sold 247 shares of common stock on August 21, 2026 at a price of $98.87 per share. After this transaction, he directly holds 28,274 shares of Itron common stock. The sale was executed under a pre-established Rule 10b5-1 Trading Plan adopted on September 11, 2025.

Rhea-AI Summary

For ITRON, INC. (ITRI), SVP & CFO Joan S. Hooper reported a set of option exercises and related share sales on August 20, 2026. She exercised stock options for a total of 5,823 shares of Common Stock at strike prices of $68.45 and $69.30 per share. On the same date, she sold 365 shares at $97.8259 per share to automatically cover tax withholding from a restricted stock unit vesting, and sold an additional 4,041 shares at $98.95 per share in open market transactions to satisfy the purchase price on the option exercises.

Rhea-AI Summary

ITRON, INC. (ITRI) reported an insider transaction by David Marshall Wright, VP, Corp. Controller & CAO. On 2026-08-20, he sold 58 shares of common stock at $97.8259 per share. According to the disclosure, these shares were automatically sold to cover tax withholding on a vesting restricted stock unit award, leaving him with 8,747 shares held directly.

Rhea-AI Summary

ITRON, INC. (ITRI) reported that officer Donald L. Reeves III, SVP, Outcomes, had 286 shares of Common Stock sold on 2026-08-20 at $97.8259 per share. According to the company’s disclosure, these shares were automatically sold to cover tax withholding obligations from the vesting of a restricted stock unit award. Following this transaction, Reeves directly held 28,521 shares of Itron common stock.

Rhea-AI Summary

ITRON, INC. (ITRI) reported an insider transaction by Christopher E. Ware, SVP, General Counsel and Corporate Secretary. On 2026-08-20, Ware had 195 shares of common stock sold at $97.8259 per share, as shares automatically sold to cover tax withholding on a vesting restricted stock unit award. Following this transaction, he directly held 30,116 shares of Itron common stock.

Rhea-AI Summary

ITRON, INC. (ITRI) reported that officer Laurie Ann Pulatie-Hahn, SVP, HR, sold 187 shares of common stock on August 20, 2026 at an average price of $97.8259 per share. According to the footnote, these shares were automatically sold to cover tax withholding obligations from the vesting of a restricted stock unit award. After this transaction, she directly held 32,108 shares of Itron common stock.

Rhea-AI Summary

ITRON, INC. (ITRI) reported an insider transaction by Patrick Justin K, SVP, Device Solutions. On 2026-08-20, he disposed of 212 shares of common stock at $97.8259 per share. According to the company’s disclosure, these shares were automatically sold to cover tax withholding obligations tied to the vesting of a restricted stock unit award, leaving him with 32,497 directly held shares.

Rhea-AI Summary

ITRON, INC. (ITRI) reported an insider transaction by John F. Marcolini, SVP, Networked Solutions. On 2026-08-20, 275 shares of Common Stock were sold at an average price of $97.8259 per share. According to the disclosure, these shares were automatically sold to cover tax withholding obligations arising from the vesting of a restricted stock unit award. After this sale, Marcolini directly held 13,014 shares of Itron common stock.

Rhea-AI Summary

ITRON, INC. (ITRI) reported an insider transaction by President & CEO Thomas Deitrich. On 2026-08-20, he sold 783 shares of common stock at $97.8259 per share, with the filing stating these shares were automatically sold to cover tax withholding obligations from a restricted stock unit vesting. Following the sale, he directly held 367,896 common shares and indirectly held 25,000 shares through a trust.

Rhea-AI Summary

Itron, Inc. director Sheri Savage reported receiving a grant of common stock as part of her board compensation. On July 1, 2026, she acquired 621 shares of Common Stock at a stated price of $0.00 per share under a grant, award, or other acquisition. Following this transaction, she directly holds 2,387 common shares. A footnote explains that independent members of Itron’s board receive these common stock grants quarterly as part of their annual compensation for board service, indicating this is a routine, compensation-related equity award rather than an open-market trade.

Rhea-AI Summary

Perez Santiago reported acquisition or exercise transactions in this Form 4 filing.

Itron director Santiago Perez received a grant of 621 shares of common stock as part of his quarterly board compensation. The stock was awarded at no cash cost to him and is described as the regular grant independent board members receive. Following this award, his direct holdings increased to 12,519 common shares.

Rhea-AI Summary

ITRON, INC. director Sanjay Mirchandani reported an acquisition of common stock through a compensation grant. On July 1, 2026, he received 621 shares of common stock at $0.00 per share as part of the quarterly equity retainer for independent board members. Following this award, his direct holdings increased to 6,824 shares of Itron common stock. This is a compensation-related grant rather than an open‑market purchase or sale.

Rhea-AI Summary

LEYDEN TIMOTHY M reported acquisition or exercise transactions in this Form 4 filing.

ITRON, INC. director Timothy M. Leyden received a grant of 248 shares of common stock as part of regular quarterly compensation for independent board members. The shares were awarded at no cash cost. Following this grant, he directly holds 16,253 common shares.

The filing notes that Mr. Leyden deferred receipt of 93 of the granted shares under Itron's Executive Deferred Compensation Plan, so only the remaining portion is received immediately while the deferred shares will be credited according to that plan's terms.

Rhea-AI Summary

Lande Jerome J. reported acquisition or exercise transactions in this Form 4 filing.

ITRON, INC. director Jerome J. Lande received a grant of 621 shares of common stock as compensation for board service. The award is part of the quarterly stock grants that independent members of Itron's board receive toward their annual compensation. Following this grant, Lande directly holds 10,765 shares of common stock.

Rhea-AI Summary

JAEHNERT FRANK M reported acquisition or exercise transactions in this Form 4 filing.

ITRON, INC. director Frank M. Jaehnert reported receiving a grant of 621 shares of common stock as part of his quarterly board compensation. The shares were awarded at no cash purchase price and increased his directly held position to 23,118 common shares. According to the disclosure, he deferred receipt of these shares under Itron's Executive Deferred Compensation Plan, meaning the award is part of his non-employee director compensation structure rather than an open-market transaction.

Rhea-AI Summary

Drury Scott D. reported acquisition or exercise transactions in this Form 4 filing.

ITRON, INC. director Scott D. Drury received a grant of 621 shares of common stock as part of his quarterly board compensation. The award was recorded at a price of $0.00 per share, reflecting that it is a compensation grant rather than a market purchase.

Following this grant, Drury directly holds 2,344 shares of Itron common stock. According to the disclosure, he deferred receipt of these shares under Itron's Executive Deferred Compensation Plan, meaning the shares are credited for his benefit but delivery is postponed.

Rhea-AI Summary

Itron, Inc. senior vice president John F. Marcolini sold 11,400 shares of Common Stock in an open-market transaction at $82.99 per share. After the sale, he directly holds 13,289 shares. The trade was executed under a pre-arranged Rule 10(b)5-1 Trading Plan adopted by Mr. Marcolini on February 23, 2026, indicating it was scheduled in advance rather than timed discretionarily.

Rhea-AI Summary

ITRON, INC. senior vice president of Outcomes Donald L. Reeves III sold 293 shares of common stock in an open-market transaction at $84.50 per share on May 27, 2026. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted by Mr. Reeves on September 11, 2025, and he continued to hold 28,807 shares of common stock directly after the transaction.

Rhea-AI Summary

Itron, Inc. executive David Marshall Wright, VP, Corp. Controller & CAO, reported selling 74 shares of common stock at $84.3667 per share. According to the footnote, these shares were automatically sold to cover tax withholding obligations tied to a restricted stock unit vesting. After this tax-related sale, he directly holds 8,805 shares of Itron common stock.

Rhea-AI Summary

Itron, Inc. reported an insider transaction by SVP, GC & Corporate Secretary Christopher E. Ware. He sold 195 shares of common stock on May 26, 2026 at an average price of $84.3667 per share. According to the footnote, these shares were automatically sold to cover tax withholding obligations from the vesting of a restricted stock unit award. After this transaction, he directly holds 30,311 shares of Itron common stock.

Rhea-AI Summary

Itron, Inc. senior vice president Donald L. Reeves III had 319 shares of common stock sold on May 26, 2026 at $84.3667 per share to cover tax withholding tied to restricted stock unit vesting. After this automatic tax-related sale, he directly owns 29,100 shares.

Rhea-AI Summary

Itron, Inc. senior vice president of HR Laurie Ann Pulatie-Hahn reported a small sale of company stock. She disposed of 174 shares of common stock at an average price of $84.3667 per share. According to the disclosure, these shares were automatically sold to cover tax withholding obligations tied to the vesting of a restricted stock unit award, making this a routine, non-discretionary transaction. After the sale, she directly holds 32,295 shares of Itron common stock.

Rhea-AI Summary

Itron, Inc. senior vice president of Device Solutions Patrick Justin K reported a small share disposition related to equity compensation. On this Form 4, he sold 216 shares of Common Stock at an average price of $84.3667 per share. According to the footnote, these shares were automatically sold to cover tax withholding obligations arising from the vesting of a restricted stock unit award, rather than a discretionary portfolio sale. After this transaction, he directly holds 32,709 shares of Itron common stock.

Rhea-AI Summary

ITRON, INC. senior vice president John F. Marcolini reported a small sale of 322 shares of Common Stock at $84.3667 per share. According to the footnote, these shares were automatically sold to cover tax withholding obligations tied to a restricted stock unit vesting, rather than a discretionary trade. After this transaction, he directly holds 24,689 shares of Itron common stock.

Rhea-AI Summary

Itron, Inc. senior vice president and CFO Joan S. Hooper reported an open-market sale of 442 shares of common stock on May 26, 2026 at an average price of $84.3667 per share. According to the filing, these shares were automatically sold to cover tax withholding obligations tied to the vesting of a restricted stock unit award.

After this tax-related sale, Hooper directly holds 117,478 shares of Itron common stock.

Rhea-AI Summary

ITRON, INC. President & CEO Thomas Deitrich reported a small disposition of company stock tied to equity compensation. On May 26, 2026, 862 shares of common stock were sold at $84.3667 per share to cover tax withholding obligations from a vesting restricted stock unit award, according to the footnote. This was not a discretionary open-market sale for portfolio reasons but a mechanistic tax payment. After the transaction, Deitrich directly owned 368,679 common shares, and a separate indirect holding entry shows 25,000 shares held by a trust. The filing therefore reflects a routine, small tax-related share disposition while the CEO maintains a substantial continuing equity stake in Itron.

Rhea-AI Summary

ITRON, INC. executive Donald L. Reeves III, SVP, Outcomes, reported an open-market sale of 255 shares of common stock on May 21, 2026 at $80.88 per share. The sale was made under a Rule 10b5-1 trading plan adopted on September 11, 2025. After this transaction, he directly holds 29,419 shares of Itron stock, indicating a relatively small, pre-planned reduction in his position.

Rhea-AI Summary

ITRON, INC. executive David Marshall Wright, VP, Corp. Controller & CAO, reported an automatic sale of common stock tied to equity compensation. On the reported date, 57 shares of common stock were sold at an average price of $79.5976 per share to cover tax withholding obligations from the vesting of a restricted stock unit award. Following this tax-related sale, Wright directly owns 8,879 shares of Itron common stock.

Rhea-AI Summary

Itron, Inc. senior vice president and general counsel Christopher E. Ware reported an automatic sale of common stock tied to restricted stock unit vesting. On May 20, 2026, 189 shares of common stock were sold at $79.5976 per share to cover tax withholding obligations from an RSU award vesting. After this tax-related sale, Ware directly holds 30,506 shares of Itron common stock, indicating the transaction affects only a small portion of his overall position.

Rhea-AI Summary

Itron, Inc. senior vice president Donald L. Reeves III reported a small share disposition tied to equity compensation. On this Form 4, 277 shares of common stock were automatically sold to cover tax withholding obligations when a restricted stock unit award vested, according to the footnote.

These tax-related shares were priced at about $79.60 each. After this routine withholding transaction, Reeves directly holds 29,674 shares of Itron common stock, indicating he retains a substantial equity stake despite the small reduction.

Rhea-AI Summary

Itron, Inc. senior vice president of HR Laurie Ann Pulatie-Hahn reported a small share sale tied to equity compensation. On May 20, she sold 181 shares of common stock at an average price of $79.5976 per share.

According to the footnote, these shares were automatically sold to cover tax withholding obligations from the vesting of a restricted stock unit award, rather than a discretionary open-market sale. After this transaction, she directly owns 32,469 Itron shares.

Rhea-AI Summary

ITRON, INC. senior vice president Patrick Justin K reported an automatic sale of common stock tied to equity compensation. On the transaction date, 206 shares were sold at an average price of $79.5976 per share to cover tax withholding obligations from the vesting of a restricted stock unit award. After this tax-related sale, he directly holds 32,925 shares of Itron common stock, indicating the transaction is small relative to his remaining stake and primarily mechanical rather than a discretionary portfolio change.

Rhea-AI Summary

ITRON, INC. senior vice president John F. Marcolini reported a small, automatic share sale tied to equity compensation. On the transaction date, 267 shares of common stock were sold at an average price of $79.5976 per share to cover tax withholding obligations from a vested restricted stock unit award. After this tax-related sale, Marcolini directly owned 25,011 shares, indicating he retained the vast majority of his holdings and that the transaction was routine rather than a discretionary reduction in ownership.

Rhea-AI Summary

ITRON, INC. SVP & CFO Joan S. Hooper reported a small share sale tied to equity compensation taxes. On the reported date, 355 shares of common stock were automatically sold at an average price of $79.5976 per share to cover tax withholding obligations from a restricted stock unit vesting.

After this transaction, Hooper directly holds 117,920 shares of Itron common stock, indicating she retains a substantial equity position while settling tax liabilities linked to her stock-based compensation.

Rhea-AI Summary

ITRON, INC. President & CEO Thomas Deitrich reported an automatic sale of 760 shares of common stock at $79.5976 per share to cover tax withholding obligations tied to a restricted stock unit vesting. After this transaction, he directly holds 369,541 shares and indirectly holds 25,000 shares through a trust.

Rhea-AI Summary

ITRON, INC. senior vice president of HR Laurie Ann Pulatie-Hahn reported a small insider transaction involving common stock. On May 11, 2026, 124 shares were sold at an average price of $81.5911 per share. A footnote explains these shares were automatically sold to cover tax withholding obligations related to the vesting of a restricted stock unit award, indicating this was a mechanical tax transaction rather than a discretionary open-market sale. After this sale, she directly owned 32,650 shares of Itron common stock, so the transaction represents a very small portion of her overall holdings.

Rhea-AI Summary

Itron, Inc. director Sheri Savage received a stock grant of 580 shares of Common Stock as part of her quarterly board compensation. The shares were awarded at no cash cost to her and are classified as a grant or other acquisition. Following this grant, she directly holds 1,766 shares of Itron common stock.

Rhea-AI Summary

Perez Santiago reported acquisition or exercise transactions in this Form 4 filing.

ITRON, INC. director Perez Santiago received a grant of 580 shares of common stock on April 1, 2026. This award is part of the quarterly stock compensation that independent board members receive for their service. After this grant, Perez Santiago directly owns 11,898 shares of Itron common stock.

Rhea-AI Summary

Mirchandani Sanjay reported acquisition or exercise transactions in this Form 4 filing.

Itron, Inc. director Sanjay Mirchandani received a stock grant of 580 shares of common stock as part of his quarterly board compensation. This grant was awarded at no cash cost per share and increased his direct holdings to 6,203 common shares following the transaction.

Rhea-AI Summary

LEYDEN TIMOTHY M reported acquisition or exercise transactions in this Form 4 filing.

Itron, Inc. director Timothy M. Leyden received a grant of 232 shares of common stock as part of the quarterly compensation that independent board members receive. The award was at no cash cost per share and increased his direct holdings to 16,005 shares.

According to the disclosure, Leyden deferred receipt of 87 of these shares under Itron's Executive Deferred Compensation Plan, so only part of the award was taken immediately in stock while the remainder was deferred.